Population
Patients with type 1 diabetes and type 2 diabetes
Design
Review
Authors
Loading...
Supports aggressive BP control in diabetes; leaves open optimal targets from contemporary trials.
Aggressive blood pressure management with lifestyle modifications and pharmacotherapy (especially ACE inhibitors and ARBs) is crucial for reducing cardiovascular and renal risk in diabetic patients.
Landsberg et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: